TrialCancer2014

Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808.

Jonathan E Kolitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.